Benevich Eric: insider trades.
Benevich Eric reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($333K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- BENEVICH ERIC
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Neurocrine Biosciences Inc (NBIX) | Officer · Chief Commercial Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | Neurocrine Biosciences Inc | A | 6,275 | $0 | 70,683 | Form 4 |
| 2026-09-11 | Neurocrine Biosciences Inc | F | 3,386 | $156.22 | 67,297 | Form 4 |
| 2026-09-09 | Neurocrine Biosciences Inc | M | 3,194 | $43.24 | 66,562 | Form 4 |
| 2026-09-09 | Neurocrine Biosciences Inc | S | 2,154 | $154.61 | 64,408 | Form 4 |
Questions
What stock did Benevich Eric buy or sell?
Benevich Eric reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($333K), across 1 company.
Is Benevich Eric the same person as other filers with this name?
This page covers SEC CIK 1643653 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/benevich-eric-1643653.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.